Vaccination against COVID-19 could offer unexpected benefits for children suffering from eczema, a chronic skin condition ...

New data supporting the safety and efficacy of tapinarof cream 1% (Vtama; Organon) for pediatric patients with atopic ...

For actress, comedian, podcaster, and OPZELURA patient Heather McMahan, eczema struggles began as a child and have “been a ...

Women with breast cancer and preexisting atopic/allergic conditions faced a heightened risk for radiodermatitis up to 36 ...

An open-source platform enables multinational analysis of dermatology registries for atopic dermatitis while safeguarding ...

Siolta Therapeutics announces positive results from phase 2 ADORED study of STMC-103H to prevent atopic diseases: San Carlos, California Wednesday, November 19, 2025, 18:00 Hrs [I ...

Siolta Therapeutics, a clinical-stage biotech company developing first-in-class live biotherapeutic products (LBPs), today announced positive top-line results from the Phase 2 ADORED study (Allergic ...

Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical-stage innovative drug development company, today announced key results from its Phase II clinical trial ...

Jeremy Rabe visits with TV super star, Tori Spelling, and Dr. Adam Friedman about treatment options for severe eczema. From ...

In this real world cohort, tralokinumab for dupilumab nonresponders reduced body surface area and pruritus scores and eased ...

Peanut allergy is one of the most common food allergies, affecting between 1% and 2% of people living in the West. And, for ...

Completed enrollment in soquelitinib atopic dermatitis Phase 1 trial extension cohort 4 (200 mg BID dose with 8-week treatment period) with data announcement anticipated in January Soquelitinib atopic ...